Analysis reveals targeting stimulation sites enhances gait outcomes in individuals with Parkinson's Disease, indicating precision matters in therapy.
These findings support precision targeting of stimulation sites to optimize patient-specific gait outcomes, advancing personalized DBS therapy in Parkinson's disease.
No takes yet. Share an insight, caveat, or question.
Mei et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: